CA
BVS icon

Clearstead Advisors’s Bioventus BVS Stock Holding History

Clearstead Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85 Buy
+9
New +$86 ﹤0.01% 3392
2026
Q1 		– Sell
-9
Closed -$67 – 2337
2025
Q4 		$67 Sell
9
-50
-85% -$359 ﹤0.01% 2572
2025
Q3 		$395 Buy
59
+57
+2,850% +$396 ﹤0.01% 2767
2025
Q2 		$14 Buy
+2
New +$14 ﹤0.01% 2718

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Clearstead Advisors's BVS Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Bioventus (BVS) in Q2 2026: 9 shares worth $85. The stake represents ﹤0.01% of the portfolio and ranks #3392 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in BVS as recently as Q4 2025.

Clearstead Advisors first reported a position in BVS in Q2 2025 and has held it in 4 quarters since. The position peaked at $395 in Q3 2025. 56 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Clearstead Advisors held 9 shares of Bioventus worth $85 as of Q2 2026.
  • Bioventus was a new Clearstead Advisors position in Q2 2026.
  • Bioventus made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3392 holding.
  • Clearstead Advisors first reported a position in Bioventus in Q2 2025 and has held it in 4 quarters since.
  • Clearstead Advisors's Bioventus position peaked at $395 in Q3 2025.
  • 56 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.